Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON) [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, placebo-controlled trial of curcumin for Leber hereditary optic neuropathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Mahidol University | Conditions: Optic Atrophy, Hereditary, Leber | Phase 3 | Status: COMPLETED